Vanguard Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $870K | Sell |
2,636,115
-472,666
| -15% | -$156K | ﹤0.01% | 3776 |
|
|
2025
Q1 | $970K | Sell |
3,108,781
-39,301
| -1% | -$12.3K | ﹤0.01% | 3719 |
|
|
2024
Q4 | $2.94M | Buy |
3,148,082
+5,643
| +0.2% | +$5.27K | ﹤0.01% | 3447 |
|
|
2024
Q3 | $3.71M | Buy |
3,142,439
+53,046
| +2% | +$62.6K | ﹤0.01% | 3380 |
|
|
2024
Q2 | $2.38M | Buy |
3,089,393
+113,085
| +4% | +$87K | ﹤0.01% | 3502 |
|
|
2024
Q1 | $9.08M | Sell |
2,976,308
-13,469
| -0.5% | -$41.1K | ﹤0.01% | 3015 |
|
|
2023
Q4 | $9.63M | Buy |
2,989,777
+23,360
| +0.8% | +$75.2K | ﹤0.01% | 2970 |
|
|
2023
Q3 | $11.4M | Buy |
2,966,417
+67,189
| +2% | +$258K | ﹤0.01% | 2818 |
|
|
2023
Q2 | $9.51M | Buy |
2,899,228
+288,626
| +11% | +$947K | ﹤0.01% | 2976 |
|
|
2023
Q1 | $6.74M | Buy |
2,610,602
+28,866
| +1% | +$74.5K | ﹤0.01% | 3165 |
|
|
2022
Q4 | $4.8M | Buy |
2,581,736
+1,146
| +0% | +$2.13K | ﹤0.01% | 3329 |
|
|
2022
Q3 | $4.75M | Buy |
2,580,590
+45,500
| +2% | +$83.7K | ﹤0.01% | 3358 |
|
|
2022
Q2 | $5.45M | Sell |
2,535,090
-1,152,819
| -31% | -$2.48M | ﹤0.01% | 3339 |
|
|
2022
Q1 | $11.6M | Buy |
3,687,909
+245,291
| +7% | +$770K | ﹤0.01% | 3073 |
|
|
2021
Q4 | $11.1M | Buy |
3,442,618
+60,537
| +2% | +$194K | ﹤0.01% | 3154 |
|
|
2021
Q3 | $11.4M | Sell |
3,382,081
-123,556
| -4% | -$415K | ﹤0.01% | 3164 |
|
|
2021
Q2 | $13.7M | Buy |
3,505,637
+9,251
| +0.3% | +$36.2K | ﹤0.01% | 3044 |
|
|
2021
Q1 | $14.1M | Buy |
3,496,386
+390,634
| +13% | +$1.57M | ﹤0.01% | 2967 |
|
|
2020
Q4 | $7.17M | Buy |
3,105,752
+509,417
| +20% | +$1.18M | ﹤0.01% | 3164 |
|
|
2020
Q3 | $14.9M | Buy |
2,596,335
+474,703
| +22% | +$2.72M | ﹤0.01% | 2591 |
|
|
2020
Q2 | $15.6M | Buy |
2,121,632
+422,661
| +25% | +$3.11M | ﹤0.01% | 2547 |
|
|
2020
Q1 | $5.06M | Buy |
1,698,971
+210,442
| +14% | +$627K | ﹤0.01% | 2969 |
|
|
2019
Q4 | $6.18M | Buy |
1,488,529
+423,961
| +40% | +$1.76M | ﹤0.01% | 3094 |
|
|
2019
Q3 | $3.45M | Sell |
1,064,568
-33,046
| -3% | -$107K | ﹤0.01% | 3270 |
|
|
2019
Q2 | $2.03M | Buy |
1,097,614
+443,490
| +68% | +$820K | ﹤0.01% | 3473 |
|
|
2019
Q1 | $1.16M | Buy |
654,124
+361,864
| +124% | +$641K | ﹤0.01% | 3585 |
|
|
2018
Q4 | $708K | Sell |
292,260
-154,510
| -35% | -$374K | ﹤0.01% | 3659 |
|
|
2018
Q3 | $2.53M | Buy |
446,770
+2,003
| +0.5% | +$11.4K | ﹤0.01% | 3452 |
|
|
2018
Q2 | $3.47M | Buy |
444,767
+44,237
| +11% | +$345K | ﹤0.01% | 3336 |
|
|
2018
Q1 | $2.83M | Buy |
400,530
+66,464
| +20% | +$470K | ﹤0.01% | 3345 |
|
|
2017
Q4 | $3.3M | Buy |
334,066
+172,409
| +107% | +$1.7M | ﹤0.01% | 3274 |
|
|
2017
Q3 | $1.39M | Buy |
161,657
+62,340
| +63% | +$534K | ﹤0.01% | 3500 |
|
|
2017
Q2 | $1.04M | Buy |
+99,317
| New | +$1.04M | ﹤0.01% | 3558 |
|